Literature DB >> 18832975

Anti-inflammatory drug use and age-related macular degeneration.

Mark W Swanson1, Gerald McGwin.   

Abstract

PURPOSE: Basic research has shown that early processes in the development of age-related macular degeneration (ARMD) are related to inflammation. The purpose of this manuscript is to evaluate the association of ARMD and the use of anti-inflammatory medications.
METHODS: A nested case control study was carried out among male patients at the Veteran's Medical Center in Birmingham, Alabama (BVAMC). Cases were 614 patients with incident ARMD diagnosed between 1997 and 2001 by International Classification of Disease, Ninth Revision code. Controls (4526) were individuals with no diagnosis of ARMD by International Classification of Disease, Ninth Revision coding and matched on age. Formulary records of all medications dispensed through the Veteran's Administration Medical Center were accessed. All oral or injectable drugs with anti-inflammatory properties were considered anti-inflammatory medications for study purposes. Topical ophthalmic and dermatologic preparations were not considered anti-inflammatory.
RESULTS: Among veterans with a diagnosis of ARMD 24% (150/614) patients had filled a prescription for any of the anti-inflammatory medications compared with 60% (3051/4526) individuals in the control population. Individuals who had filled a prescription for anti-inflammatory drugs had an 85% reduced odds of having a diagnosis of ARMD (odds ratio 0.15, 95% confidence interval 0.12-0.18).
CONCLUSIONS: The results of this study suggest that veterans who had filled a prescription for anti-inflammatory medications had a reduced risk of ARMD. Further studies are needed to confirm this result.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832975     DOI: 10.1097/OPX.0b013e31818883e0

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  6 in total

1.  Association of Anticholinergic Drug Use With Risk for Late Age-Related Macular Degeneration.

Authors:  Gauthier Aldebert; Jean-Luc Faillie; Dominique Hillaire-Buys; Thibault Mura; Isabelle Carrière; Cécile Delcourt; Catherine Creuzot-Garcher; Max Villain; Vincent Daien
Journal:  JAMA Ophthalmol       Date:  2018-07-01       Impact factor: 7.389

2.  SYSTEMIC MEDICATION USE AND THE INCIDENCE AND GROWTH OF GEOGRAPHIC ATROPHY IN THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENTS TRIALS.

Authors:  Delu Song; Peiying Hua; Brian L VanderBeek; Joshua L Dunaief; Juan E Grunwald; Ebenezer Daniel; Maureen G Maguire; Daniel F Martin; Gui-Shuang Ying
Journal:  Retina       Date:  2021-07-01       Impact factor: 3.975

3.  The Relationship between Neutrophil-to-lymphocyte Ratio and Age-related Macular Degeneration.

Authors:  Bengi Ece Kurtul; Pinar Altiaylik Ozer
Journal:  Korean J Ophthalmol       Date:  2016-09-29

Review 4.  Medication Trends for Age-Related Macular Degeneration.

Authors:  Yeon-Kyoung Cho; Dae-Hun Park; In-Chul Jeon
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

Review 5.  Parainflammation, chronic inflammation, and age-related macular degeneration.

Authors:  Mei Chen; Heping Xu
Journal:  J Leukoc Biol       Date:  2015-08-20       Impact factor: 4.962

6.  Non-steroidal Anti-inflammatory Drug Use and Risk of Age-Related Macular Degeneration in the California Teachers Study.

Authors:  Xiaoqing Xu; Beate Ritz; Anne L Coleman; Zeyan Liew; Dennis Deapen; Eunjung Lee; Leslie Bernstein; Rich Pinder; Sarah F Marshall; Julia E Heck
Journal:  Drugs Aging       Date:  2021-07-26       Impact factor: 3.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.